Amgen Inc. Stock Performance

Open $405.00	Prev. Close $407.59	Circuit Range N/A
Day Range $404.05 - $417.78	Year Range $288.32 - $447.03	Volume 1,10,229
Average Traded $413.28

Amgen Inc. Share Price Today

As of 10 October 2026, Amgen Inc.'s share price is $414.93. The stock opened at $405.00, compared to its previous close of $407.59. During today's trading session, Amgen Inc.'s share price traded between $404.05 and $417.78, with an average price of $410.91. Over the past 52 weeks, the stock has recorded a high of $447.03 and a low of $288.32. In terms of performance, Amgen Inc.'s share price has risen by 19.85% over the last six months and is up 39.03% on a year-on-year basis.

Amgen Inc. Share Price Chart

$404.05$417.78

Amgen Inc. Stock Fundamentals & Key Indicators

Market Cap $223.23B	PE Ratio (TTM) 25.19	Dividend Yield 2.40%
EPS (TTM) $16.17	Revenue (TTM) $36.75B	Return On Equity (TTM) 74.80%
Profit Margin 20.98%	Debt to Equity 4.90	Quarterly Earnings Growth YoY -26.09%

Amgen Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$9.56	$9.87	$8.62	$10.05
Net Profit	$3.22	$1.33	$1.82	$2.38
Net Profit Margin	33.68%	13.48%	21.11%	23.68%
Income Change	N/A	-58.70%	36.84%	30.77%

Amgen Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$26.32	$28.19	$33.42	$36.75
Net Profit	$6.55	$6.72	$4.09	$7.71
Net Profit Margin	24.89%	23.84%	12.24%	20.98%
Income Change	N/A	2.60%	-39.14%	88.51%

About Amgen Inc.

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$421.95	$415.07	-1.66%
Sep 2026	$432.49	$422.08	-3.40%
Aug 2026	$389.64	$436.92	+13.42%
Jul 2026	$362.47	$385.21	+6.37%
Jun 2026	$333.00	$362.15	+7.54%
May 2026	$334.89	$336.77	-2.73%
Apr 2026	$354.90	$346.22	-1.61%
Mar 2026	$386.63	$351.87	-9.33%
Feb 2026	$340.82	$388.10	+13.48%
Jan 2026	$328.69	$341.99	+4.47%
Dec 2025	$343.14	$327.35	-5.23%
Nov 2025	$298.44	$345.43	+15.74%

AMGN Share Price FAQs

What is Amgen Inc. share price today?

Amgen Inc. share price today is $414.93 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Amgen Inc. stock?

The 52 week high of Amgen Inc. stock is $447.03, while the 52 week low is $288.32 as of 10 Oct '26.

What is AMGN's market capitalisation today?

AMGN market capitalisation is $223.23B as of October 10, 2026, at 4:42 am IST.

What is AMGN's net income for the last quarter?

AMGN's net income for the last quarter is 2.38B USD.

What is the 5 year returns of AMGN?

The 5 year returns of AMGN is 100.45% as on 10 Oct '26.

What is the high & low stock price of AMGN today?

AMGN stock price hit a high of $417.78 and low of $404.05 as of 10 Oct '26.

Can I buy AMGN shares in India?

Yes. You can buy AMGN in India by opening an international trading account.